Skip to main content
Erschienen in: Endocrine 2/2017

04.10.2016 | Original Article

Cushing’s syndrome and pregnancy outcomes: a systematic review of published cases

verfasst von: Francisca Caimari, Elena Valassi, Patricia Garbayo, Charlotte Steffensen, Alicia Santos, Rosa Corcoy, Susan M. Webb

Erschienen in: Endocrine | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Pregnancy in Cushing’s syndrome (CS) is extremely rare due to the influence of hypercortisolism on the reproductive axis. Purpose of this study is to investigate whether the etiology of CS in pregnancy determines a different impact on the fetal/newborn and maternal outcomes. We performed a systematic review of cases published in the literature from January 1952 to April 2015 including the words “Cushing AND pregnancy”. We included 168 manuscripts containing 220 patients and 263 pregnancies with active CS during pregnancy and with a history of CS but treated and cured hypercortisolism at the time of gestation. Adrenal adenoma was the main cause of active CS during pregnancy (44.1 %). Women with active CS had more gestational diabetes mellitus (36.9 vs. 2.3 %, p = 0.003), gestational hypertension (40.5 vs. 2.3 %, p < 0.001) and preeclampsia (26.3 vs. 2.3 %, p = 0.001) than those with cured disease. The proportion of fetal loss in active CS was higher than in cured CS (23.6 vs. 8.5 %, p = 0.021), as well as global fetal morbidity (33.3 vs. 4.9 %, p < 0.001). The predictors of fetal loss in active CS were etiology of hypercortisolism [Odds Ratio –OR—for pregnancy-induced CS 4.7 (95 % Confidence Interval–CI 1.16–18.96), p = 0.03], publication period [OR for “1975–1994” 0.10 (95 % CI 0.03–0.40), p = 0.001] and treatment during gestation (p = 0.037, [OR medical treatment 0.25 (95 % CI 0.06–1.02), p = 0.052], [OR surgical treatment 0.34 (95 % CI 0.11–1.06), p = 0.063]). The period of diagnosis of CS (before, during or after pregnancy) was the only predictor of overall fetal morbimortality [OR for diagnosis during pregnancy 4.66 (95 % CI 1.37–15.83), p = 0.014]. Patients with active CS, especially in pregnancy-induced CS, experienced more problems in pregnancy and had the worst fetal prognosis in comparison to other causes. Diagnosis of CS during pregnancy was also associated with worse overall fetal morbimortality. Both medical treatment and surgery during pregnancy appeared to be protective in avoiding fetal loss.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat S.T. Sharma, L.K. Nieman, R.A. Feelders, Cushing’s syndrome : epidemiology and developments in disease management. Clin. Epidemiol. 7, 281–293 (2015)PubMedPubMedCentral S.T. Sharma, L.K. Nieman, R.A. Feelders, Cushing’s syndrome : epidemiology and developments in disease management. Clin. Epidemiol. 7, 281–293 (2015)PubMedPubMedCentral
2.
Zurück zum Zitat M. Darocas, N. Ruiz, M.T. Bergoglio, A. Cano, A decision dilemma: Cushing syndrome during pregnancy. J. Obstet. Gynaecol. (Lahore) 35(1), 93–94 (2015)CrossRef M. Darocas, N. Ruiz, M.T. Bergoglio, A. Cano, A decision dilemma: Cushing syndrome during pregnancy. J. Obstet. Gynaecol. (Lahore) 35(1), 93–94 (2015)CrossRef
3.
Zurück zum Zitat B.A. Laway, S.A. Mir, Pregnancy and pituitary disorders: challenges in diagnosis and management. Indian J. Endocrinol. Metab. 17(6), 996–1004 (2013)CrossRefPubMedPubMedCentral B.A. Laway, S.A. Mir, Pregnancy and pituitary disorders: challenges in diagnosis and management. Indian J. Endocrinol. Metab. 17(6), 996–1004 (2013)CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat D. Abdelmannan, D.C. Aron, Adrenal disorders in pregnancy. Endocrinol. Metab. Clin. North Am. 40(4), 779–794 (2011)CrossRefPubMed D. Abdelmannan, D.C. Aron, Adrenal disorders in pregnancy. Endocrinol. Metab. Clin. North Am. 40(4), 779–794 (2011)CrossRefPubMed
5.
Zurück zum Zitat L. Vilar, M.C. Freitas, L.H. Lima, R. Lyra, C.E. Kater, Cushing’s Syndrome in Pregnancy : an Overview. Arq. Bras. Endocrinol. Metabol. 51(8), 1293–1302 (2007)PubMed L. Vilar, M.C. Freitas, L.H. Lima, R. Lyra, C.E. Kater, Cushing’s Syndrome in Pregnancy : an Overview. Arq. Bras. Endocrinol. Metabol. 51(8), 1293–1302 (2007)PubMed
6.
7.
Zurück zum Zitat M.D. Bronstein, M.C. Machado, Fragoso MCBV. management of endocrine disease: Management of the pregnant patient with Cushings. Eur. J. Endocrinol. 173(2), R85–R91 (2015)CrossRefPubMed M.D. Bronstein, M.C. Machado, Fragoso MCBV. management of endocrine disease: Management of the pregnant patient with Cushings. Eur. J. Endocrinol. 173(2), R85–R91 (2015)CrossRefPubMed
8.
Zurück zum Zitat M. Kamoun, M.F. Mnif, N. Charfi, F.H. Kacem, B.B. Naceur, F. Mnif et al., Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies. Am. J. Med. Sci. 347(1), 64–73 (2014)CrossRefPubMed M. Kamoun, M.F. Mnif, N. Charfi, F.H. Kacem, B.B. Naceur, F. Mnif et al., Adrenal diseases during pregnancy: pathophysiology, diagnosis and management strategies. Am. J. Med. Sci. 347(1), 64–73 (2014)CrossRefPubMed
9.
Zurück zum Zitat D.B. Schwartz, Y. Daoud, P. Zazula, G. Goyert, R. Bronsteen, D. Wright et al., Gestational diabetes mellitus: metabolic and blood glucose parameters in singleton versus twin pregnancies. Am. J. Obstet. Gynecol. 181(4), 912–914 (1999)CrossRefPubMed D.B. Schwartz, Y. Daoud, P. Zazula, G. Goyert, R. Bronsteen, D. Wright et al., Gestational diabetes mellitus: metabolic and blood glucose parameters in singleton versus twin pregnancies. Am. J. Obstet. Gynecol. 181(4), 912–914 (1999)CrossRefPubMed
10.
Zurück zum Zitat M.D. Bronstein, D.B. Paraiba, R.S. Jallad, Management of pituitary tumors in pregnancy. Nat. Rev. Endocrinol. 7(5), 301–310 (2011)CrossRefPubMed M.D. Bronstein, D.B. Paraiba, R.S. Jallad, Management of pituitary tumors in pregnancy. Nat. Rev. Endocrinol. 7(5), 301–310 (2011)CrossRefPubMed
11.
Zurück zum Zitat M.A. Buescher, H.D. McClamrock, E.Y. Adashi, Cushing syndrome in pregnancy. Obstet. Gynecol. 79(1), 130–137 (1992)PubMed M.A. Buescher, H.D. McClamrock, E.Y. Adashi, Cushing syndrome in pregnancy. Obstet. Gynecol. 79(1), 130–137 (1992)PubMed
12.
Zurück zum Zitat J.R. Lindsay, J. Jonklaas, E.H. Oldfield, L.K. Nieman, Cushing’s syndrome during pregnancy: personal experience and review of the literature. J. Clin. Endocrinol. Metab. 90(5), 3077–3083 (2005)CrossRefPubMed J.R. Lindsay, J. Jonklaas, E.H. Oldfield, L.K. Nieman, Cushing’s syndrome during pregnancy: personal experience and review of the literature. J. Clin. Endocrinol. Metab. 90(5), 3077–3083 (2005)CrossRefPubMed
13.
Zurück zum Zitat N. Polli, F. Pecori Giraldi, F. Cavagnini, Cushing’s syndrome in pregnancy. J. Endocrinol. Invest. 26(10), 1045–1050 (2003)CrossRefPubMed N. Polli, F. Pecori Giraldi, F. Cavagnini, Cushing’s syndrome in pregnancy. J. Endocrinol. Invest. 26(10), 1045–1050 (2003)CrossRefPubMed
14.
Zurück zum Zitat N. Achong, M.D. Emden, N. Fagermo, R. Mortimer, Pregnancy-induced Cushing ’ s syndrome in recurrent pregnancies : case report and literature review. Aust. New Zeal. J. Obstet. Gynaecol. 52(1), 96–100 (2012)CrossRef N. Achong, M.D. Emden, N. Fagermo, R. Mortimer, Pregnancy-induced Cushing ’ s syndrome in recurrent pregnancies : case report and literature review. Aust. New Zeal. J. Obstet. Gynaecol. 52(1), 96–100 (2012)CrossRef
15.
Zurück zum Zitat E. Rask, E. Schvarcz, P. Hellman, J. Hennings, F.A. Karlsson, C.V. Rao, Adrenocorticotropin-independent Cushing ’ s syndrome in hormone / human chorionic gonadotropin receptors. J. Endocrinol. Invest. 32(4), 313–316 (2009)CrossRefPubMed E. Rask, E. Schvarcz, P. Hellman, J. Hennings, F.A. Karlsson, C.V. Rao, Adrenocorticotropin-independent Cushing ’ s syndrome in hormone / human chorionic gonadotropin receptors. J. Endocrinol. Invest. 32(4), 313–316 (2009)CrossRefPubMed
16.
Zurück zum Zitat M.H. Chui, N.C. Özbey, S.L. Asa, Case Report : adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing ’ s Syndrome. Endocr. Pathol. 20(4), 256–261 (2009)CrossRefPubMed M.H. Chui, N.C. Özbey, S.L. Asa, Case Report : adrenal LH/hCG receptor overexpression and gene amplification causing pregnancy-induced Cushing ’ s Syndrome. Endocr. Pathol. 20(4), 256–261 (2009)CrossRefPubMed
17.
Zurück zum Zitat L. Tripto-Shkolnik, Z. Blumenfeld, M. Bronshtein, A. Salmon, Pregnancy in a patient with adrenal carcinoma treated with mitotane : a case report and review of literature. J. Clin. Endocrinol. Metab. 98(2), 443–447 (2013)CrossRefPubMed L. Tripto-Shkolnik, Z. Blumenfeld, M. Bronshtein, A. Salmon, Pregnancy in a patient with adrenal carcinoma treated with mitotane : a case report and review of literature. J. Clin. Endocrinol. Metab. 98(2), 443–447 (2013)CrossRefPubMed
18.
Zurück zum Zitat J.M. Koerten, W.J. Morales, S.R. Washington, T.W. Castaldo, Cushing’s syndrome in pregnancy: a case report and literature review. Am. J. Obstet. Gynecol. 154(3), 626–628 (1986)CrossRefPubMed J.M. Koerten, W.J. Morales, S.R. Washington, T.W. Castaldo, Cushing’s syndrome in pregnancy: a case report and literature review. Am. J. Obstet. Gynecol. 154(3), 626–628 (1986)CrossRefPubMed
19.
Zurück zum Zitat S.E. Jones, D. Carr, J. Hoffman, J. Macaulay, P. Tait, Cushing ’ s syndrome in pregnancy due to an adrenocorticotropin secreting islet cell tumour Case report. J. Obstet. Gynaecol. 19(3), 303 (1999)CrossRefPubMed S.E. Jones, D. Carr, J. Hoffman, J. Macaulay, P. Tait, Cushing ’ s syndrome in pregnancy due to an adrenocorticotropin secreting islet cell tumour Case report. J. Obstet. Gynaecol. 19(3), 303 (1999)CrossRefPubMed
20.
Zurück zum Zitat W.H. Lim, D.J. Torpy, W.S. Jeffries, The medical management of Cushing’s syndrome during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 168(1), 1–6 (2013)CrossRefPubMed W.H. Lim, D.J. Torpy, W.S. Jeffries, The medical management of Cushing’s syndrome during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 168(1), 1–6 (2013)CrossRefPubMed
21.
Zurück zum Zitat S. Sam, M.E. Molitch, Timing and special concerns regarding endocrine surgery during pregnancy. Endocrinol Metab Clin North Am. 32(2), 337–354 (2003)CrossRefPubMed S. Sam, M.E. Molitch, Timing and special concerns regarding endocrine surgery during pregnancy. Endocrinol Metab Clin North Am. 32(2), 337–354 (2003)CrossRefPubMed
22.
Zurück zum Zitat A.H. Mokdad, B.A. Bowman, E.S. Ford, F. Vinicor, J.S. Marks, J.P. Koplan, The continuing epidemics of obesity and diabetes in the United States. JAMA 286(10), 1195–1200 (2001)CrossRefPubMed A.H. Mokdad, B.A. Bowman, E.S. Ford, F. Vinicor, J.S. Marks, J.P. Koplan, The continuing epidemics of obesity and diabetes in the United States. JAMA 286(10), 1195–1200 (2001)CrossRefPubMed
23.
Zurück zum Zitat A.H. Mokdad, E.S. Ford, B.A. Bowman, D.E. Nelson, M.M. Engelgau, F. Vinicor et al., Diabetes trends in the U.S.: 1990–1998. Diabetes Care 23(9), 1278–1283 (2000)CrossRefPubMed A.H. Mokdad, E.S. Ford, B.A. Bowman, D.E. Nelson, M.M. Engelgau, F. Vinicor et al., Diabetes trends in the U.S.: 1990–1998. Diabetes Care 23(9), 1278–1283 (2000)CrossRefPubMed
24.
Zurück zum Zitat A. Delabaere, C. Huchon, X. Deffieux, G. Beucher, V. Gallot, S. Nedellec et al., Epidemiology of loss pregnancy. J. Gynecol. Obstet. Biol. Reprod. (Paris) 43(10), 764–775 (2014)CrossRef A. Delabaere, C. Huchon, X. Deffieux, G. Beucher, V. Gallot, S. Nedellec et al., Epidemiology of loss pregnancy. J. Gynecol. Obstet. Biol. Reprod. (Paris) 43(10), 764–775 (2014)CrossRef
25.
Zurück zum Zitat B.S. Buckley, J. Harreiter, P. Damm, R. Corcoy, A. Chico, D. Simmons et al., Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet. Med. 29(7), 844–854 (2012)CrossRefPubMed B.S. Buckley, J. Harreiter, P. Damm, R. Corcoy, A. Chico, D. Simmons et al., Gestational diabetes mellitus in Europe: prevalence, current screening practice and barriers to screening. A review. Diabet. Med. 29(7), 844–854 (2012)CrossRefPubMed
26.
Zurück zum Zitat E. Abalos, C. Cuesta, G. Carroli, Z. Qureshi, M. Widmer, J.P. Vogel et al., Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 121(Suppl), 14–24 (2014)CrossRefPubMed E. Abalos, C. Cuesta, G. Carroli, Z. Qureshi, M. Widmer, J.P. Vogel et al., Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: a secondary analysis of the World Health Organization Multicountry Survey on Maternal and Newborn Health. BJOG 121(Suppl), 14–24 (2014)CrossRefPubMed
27.
Zurück zum Zitat I. Ostlund, U. Hanson, Occurrence of gestational diabetes mellitus and the value of different screening indicators for the oral glucose tolerance test. Acta Obstet. Gynecol. Scand. 82(2), 103–108 (2003)CrossRefPubMed I. Ostlund, U. Hanson, Occurrence of gestational diabetes mellitus and the value of different screening indicators for the oral glucose tolerance test. Acta Obstet. Gynecol. Scand. 82(2), 103–108 (2003)CrossRefPubMed
28.
Zurück zum Zitat J. Norman, D. Politz, L. Politz, Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin. Endocrinol. (Oxf). 71(1), 104–109 (2009)CrossRefPubMed J. Norman, D. Politz, L. Politz, Hyperparathyroidism during pregnancy and the effect of rising calcium on pregnancy loss: a call for earlier intervention. Clin. Endocrinol. (Oxf). 71(1), 104–109 (2009)CrossRefPubMed
29.
Zurück zum Zitat O.M. Dekkers, E. Horváth-Puhó, J.O.L. Jørgensen, S.C. Cannegieter, V. Ehrenstein, J.P. Vandenbroucke et al., Multisystem Morbidity and Mortality in Cushing’s Syndrome: A Cohort Study. J. Clin. Endocrinol. Metab. 98(6), 2277–2284 (2013)CrossRefPubMed O.M. Dekkers, E. Horváth-Puhó, J.O.L. Jørgensen, S.C. Cannegieter, V. Ehrenstein, J.P. Vandenbroucke et al., Multisystem Morbidity and Mortality in Cushing’s Syndrome: A Cohort Study. J. Clin. Endocrinol. Metab. 98(6), 2277–2284 (2013)CrossRefPubMed
30.
Zurück zum Zitat J. Poorolajal, P. Cheraghi, Z. Cheraghi, M. Ghahramani, A.D. Irani, Predictors of miscarriage : a matched case-control study. Epidemiol. Health 36, 1–7 (2014) J. Poorolajal, P. Cheraghi, Z. Cheraghi, M. Ghahramani, A.D. Irani, Predictors of miscarriage : a matched case-control study. Epidemiol. Health 36, 1–7 (2014)
31.
Zurück zum Zitat K. Pazol, A.A. Creanga, D.J. Jamieson, Abortion Surveillance - United States, 2012. MMWR Surveill. Summ. 64(10), 1–40 (2015)CrossRefPubMed K. Pazol, A.A. Creanga, D.J. Jamieson, Abortion Surveillance - United States, 2012. MMWR Surveill. Summ. 64(10), 1–40 (2015)CrossRefPubMed
32.
Zurück zum Zitat D. Dong, H. Li, H. Xiao, The diagnosis and management of Cushing syndrome during pregnancy. J. Obstet. Gynaecol. 35(1), 94–96 (2015)CrossRefPubMed D. Dong, H. Li, H. Xiao, The diagnosis and management of Cushing syndrome during pregnancy. J. Obstet. Gynaecol. 35(1), 94–96 (2015)CrossRefPubMed
33.
Zurück zum Zitat R.N. Sammour, L. Saiegh, I. Matter, R. Gonen, C. Shechner, M. Cohen et al., Adrenalectomy for adrenocortical adenoma causing Cushing’s syndrome in pregnancy: a case report and review of literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 165(1), 1–7 (2012)CrossRefPubMed R.N. Sammour, L. Saiegh, I. Matter, R. Gonen, C. Shechner, M. Cohen et al., Adrenalectomy for adrenocortical adenoma causing Cushing’s syndrome in pregnancy: a case report and review of literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 165(1), 1–7 (2012)CrossRefPubMed
34.
Zurück zum Zitat A. Klibanski, A.E. Stephen, M.F. Greene, M.A. Blake, C. Wu, Case 36-2006 : A 35-year-old pregnant woman with new hypertension. N. Engl. J. Med. 355(21), 2237–2245 (2006)CrossRefPubMed A. Klibanski, A.E. Stephen, M.F. Greene, M.A. Blake, C. Wu, Case 36-2006 : A 35-year-old pregnant woman with new hypertension. N. Engl. J. Med. 355(21), 2237–2245 (2006)CrossRefPubMed
35.
Zurück zum Zitat A.P.H. Prebtani, D. Donat, S. Ezzat, Worrisome striae. Lancet 355(9), 2000 (2000) A.P.H. Prebtani, D. Donat, S. Ezzat, Worrisome striae. Lancet 355(9), 2000 (2000)
36.
Zurück zum Zitat M. Boronat, D. Marrero, Y. López-Plasencia, M. Barber, Y. Schamann, F.J. Nóvoa, Successful outcome of pregnancy in a patient with Cushing’s disease under treatment with ketoconazole during the first trimester of gestation. Gynecol. Endocrinol. 27(9), 675–677 (2011)CrossRefPubMed M. Boronat, D. Marrero, Y. López-Plasencia, M. Barber, Y. Schamann, F.J. Nóvoa, Successful outcome of pregnancy in a patient with Cushing’s disease under treatment with ketoconazole during the first trimester of gestation. Gynecol. Endocrinol. 27(9), 675–677 (2011)CrossRefPubMed
37.
Zurück zum Zitat N.J. Kassebaum, A. Bertozzi-Villa, M.S. Coggeshall, Ka Shackelford, C. Steiner, K.R. Heuton et al., Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9947), 980–1004 (2014)CrossRefPubMedPubMedCentral N.J. Kassebaum, A. Bertozzi-Villa, M.S. Coggeshall, Ka Shackelford, C. Steiner, K.R. Heuton et al., Global, regional, and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384(9947), 980–1004 (2014)CrossRefPubMedPubMedCentral
Metadaten
Titel
Cushing’s syndrome and pregnancy outcomes: a systematic review of published cases
verfasst von
Francisca Caimari
Elena Valassi
Patricia Garbayo
Charlotte Steffensen
Alicia Santos
Rosa Corcoy
Susan M. Webb
Publikationsdatum
04.10.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 2/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1117-0

Weitere Artikel der Ausgabe 2/2017

Endocrine 2/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.